While the experimentation of the medical use of cannabis framed by the National Agency for Medicines began in France on... View Article
Author Archives for Adeline Chauvigné
New member | LaFleur by DelleD
8 June 2025While the experimentation of the medical use of cannabis framed by the National Agency for Medicines began in France on... View Article
Update on XENOTHERA’s news
In March, XENOTHERA went on digging its wake to analyze the clinical efficacy of XAV-19. Marchwas the month for the... View Article
Update on XENOTHERA’s news
8 June 2025In March, XENOTHERA went on digging its wake to analyze the clinical efficacy of XAV-19. Marchwas the month for the... View Article
New member | Bioprox Healthcare
BIOPROX HEALTHCARE produces probiotics of bacterial origin belonging to about thirty different species mainly Lactobacillus (former genus name) and Bifidobacterium isolated from human... View Article
New member | Bioprox Healthcare
8 June 2025BIOPROX HEALTHCARE produces probiotics of bacterial origin belonging to about thirty different species mainly Lactobacillus (former genus name) and Bifidobacterium isolated from human... View Article
New member | Genourob
Genourob design, produce and commercialize medical devices for helping ACL tears diagnosis and for rehabilitation and fitness. Genourob has become the world... View Article
New member | Genourob
8 June 2025Genourob design, produce and commercialize medical devices for helping ACL tears diagnosis and for rehabilitation and fitness. Genourob has become the world... View Article
Valneva reports positive phase 1/2 data for its inactivated, adjuvanted COVID-19 vaccine candidate
VLA2001 was well tolerated with no safety concerns identified In the high dose group : IgG seroconversion rate of 100%... View Article
Valneva reports positive phase 1/2 data for its inactivated, adjuvanted COVID-19 vaccine candidate
8 June 2025VLA2001 was well tolerated with no safety concerns identified In the high dose group : IgG seroconversion rate of 100%... View Article
OSE Immunotherapeutics receives authorization for phase 1 clinical trial of its multi-target multi-variant COVID-19 vaccine
CoVepiT is a SARS-COV-2 vaccine activating T cell defenses through CD8 T-cell multiepitope* responses. CoVepiT epitopes are selected from 11... View Article
OSE Immunotherapeutics receives authorization for phase 1 clinical trial of its multi-target multi-variant COVID-19 vaccine
8 June 2025CoVepiT is a SARS-COV-2 vaccine activating T cell defenses through CD8 T-cell multiepitope* responses. CoVepiT epitopes are selected from 11... View Article
Immunotherapeutics in the fight against liver cancer: a world first for Rennes University Hospital and the Eugène Marquis Centre
With over 10,000 new cases every year, liver cancer is one of the most difficult cancers to treat. In Rennes,... View Article
Immunotherapeutics in the fight against liver cancer: a world first for Rennes University Hospital and the Eugène Marquis Centre
8 June 2025With over 10,000 new cases every year, liver cancer is one of the most difficult cancers to treat. In Rennes,... View Article
France Relance | Achievements in the Grand Ouest region
Source: Press release – France Relance This year, the COVID-19 health crisis has done much to reinforce the conviction that... View Article
France Relance | Achievements in the Grand Ouest region
8 June 2025Source: Press release – France Relance This year, the COVID-19 health crisis has done much to reinforce the conviction that... View Article
AFFILOGIC | Relocating its production capabilities
Winner of the French Resilience Call for Proposals in late 2020, Affilogic, a cluster member specialising in the discovery and... View Article
AFFILOGIC | Relocating its production capabilities
8 June 2025Winner of the French Resilience Call for Proposals in late 2020, Affilogic, a cluster member specialising in the discovery and... View Article
New member | Apo Tech Care
Apo Tech Care’s mission is to be the facilitator in implementing a real care 4.0 (participative, personalized, preventive and predictive),... View Article
New member | Apo Tech Care
8 June 2025Apo Tech Care’s mission is to be the facilitator in implementing a real care 4.0 (participative, personalized, preventive and predictive),... View Article